Trial intelligence / Profile preview

Remimazolam Tosilate vs Propofol for General Anesthesia

ChiCTR2000034031Phase 4Recruiting

Sponsor
First People's Hospital of Lianyungang City
Start
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of remimazolam (2 arms), sponsored by First People's Hospital of Lianyungang City. Primary endpoint: Success rate of anesthesia and sedation. Started Jul 2020; status: recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2000034031.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000034031.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call